January 8, 2010 - The Prostate Cancer Foundation (PCF) will fund at least 10 new Creativity and 20 new multi-year Young Investigator Awards in the first half of 2010 to support innovative research in the field of cancer research.

This new round of funding will support many projects that would otherwise be left unfunded due to cutbacks in federal funding and the global recession.

"We are delighted to announce that we will be funding more than 30 new game-changing research projects in 2010 in addition to the 48 research programs that we are already supporting," commented Jonathan W. Simons, M.D., president, CEO, and David H. Koch, chair of the Prostate Cancer Foundation.

"The commitment of our donors enables us to continue advancing cancer research at a time when other funding sources are shrinking. In 2009, PCF donors contributed more than U.S. $36.5 million-just shy of our 2008 total of $37.2 million-to support PCF's research enterprise. Gifts to the PCF ranged from $5.00 to $5 million. We are grateful to our supporters, both large and small, for making ongoing research progress against prostate cancer possible," they said in a public statement.

PCF funded 10 Creativity Awards in 2009 and 20 Young Investigators in 2008. The foundation will release its list of 2010 Young Investigators in March. The deadline for the Creativity Awards Request for Applications is January 31.

"PCF's Creativity and Young Investigator programs are designed to accelerate scientific research and discovery for funding new treatments and ultimately cures for this disease," commented Howard Soule, Ph.D., PCF's chief science officer responsible for overseeing the foundation's funded research programs. "Traditionally, 70 percent of our Creativity Award recipients go on to earn additional funding for their programs. Our Young Investigators are the human capital bringing new ideas to cancer research. They are energizing the fight against prostate as well as other cancers."

For more information: www.pcf.org


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now